MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    A Need for Improving the Diet Quality of Individuals with Parkinson’s Disease

    S. Mandali, K. Lyons, R. Pahwa, A. Lee (Kansas City, USA)

    Objective: This is a quality improvement project undertaken with an aim to evaluate the diet quality and adherence to the Mediterranean diet among individuals with…
  • 2023 International Congress

    Practices of neurologists in the management of Parkinson’s disease patients in the Republic of Moldova

    L. Rotaru, O. Grosu (Chisinau, Republic of Moldova)

    Objective: The aim of the study was to analyze practices of Moldovan neurologists regarding the management of Parkinson’s disease patients. Background: Parkinson’s disease management depends…
  • 2023 International Congress

    Prediction of postoperative delirium after deep brain stimulation surgery in Parkinson`s disease

    M. Astalosch, M. Mousavi, L. Martins Ribeiro, GH. Schneider, H. Stuke, S. Haufe, F. Borchers, C. Spies, J. von Hofen-Hohloch, B. Al-Fatly, G. Ebersbach, C. Franke, A. Kühn, D. Kübler-Weller (Berlin, Germany)

    Objective: - To identify risk factors for postoperative delirium (POD) after deep brain stimulation (DBS) surgery- To personalize and optimize perioperative management Background: The main…
  • 2023 International Congress

    Prevalence of cogwheel phenomenon in Parkinson disease

    S. Barua, W. Chouhani, A. D’Abreu, J. Friedman, U. Akbar (Providence, USA)

    Objective: To examine the prevalence of cogwheel rigidity (CWR) in a cohort of Parkinson disease (PD) patients Background: First noted in a 1901 publication, CWR…
  • 2023 International Congress

    Altered nucleus accumbens functional connectivity precedes apathy in Parkinson’s disease

    L. Morris, S. Harrison, T. Melzer, J. Dalrymple-Alford, T. Anderson, M. Macaskill, C. Le Heron (Christchurch, New Zealand)

    Objective: To investigate whether changes in connectivity between neural regions that are associated with goal-directed behaviour predict future development of apathy in people with Parkinson’s…
  • 2023 International Congress

    Characterization of the pathogenic α-Synuclein variant p.V15A in Parkinson´s disease

    S H. Diaw, F. Buratti, L. Streubel-Gallasch, M. Borsche, M. Dulovic-Mahlow, C O. Fernández, J. Seeliger, I. Lenz, P. Seibler, C. Klein, N. Brüggemann, M. Zweckstetter, M. Vos, K. Lohmann (Lübeck, Germany)

    Objective: To investigate functional alterations of the p.V15A variant in alpha-Synuclein (α-Syn) in Parkinson's disease (PD). Background: PD is marked by the loss of dopaminergic…
  • 2023 International Congress

    The characterization of Parkinson’s disease related nociplastic pain based on the classification system

    T. Tezuka, T. Nukariya, S. Okusa, Y. Nihei, J. Nakahara, M. Seki (Tokyo, Japan)

    Objective: The characteristics of Parkinson’s disease (PD)-related nociplastic pain were evaluated by using various indicators including PD pain classification system (PD-PCS), King's Parkinson Disease Pain…
  • 2023 International Congress

    Novel modifiers of heterozygous pathogenic Parkin variant penetrance in Parkinson’s disease

    A. Hach, Z. Landoulsi, B. Meier, P. Seibler, C. Klein, P. May, A. Rakovic (Luebeck, Germany)

    Objective: To identify novel genes and pathways acting as modifiers of pathogenic Parkin variant (PV) penetrance in affected compared to unaffected carriers of heterozygous Parkin PVs…
  • 2023 International Congress

    A 16-week open-label study of the effects of treatment with pimavanserin on activities of daily living in subjects with Parkinson’s disease psychosis (PDP)

    V. Evidente, D. Dekarske, B. Coate, V. Abler (Scottsdale, USA)

    Objective: To examine the effects of pimavanserin on activities of daily living during treatment for Parkinson’s Disease psychosis. Background: Accurate assessment of disability associated with…
  • 2023 International Congress

    Olfactory dysfunction as a predictor of the future development of parkinsonism in COVID patients

    M. de Rosa, D. Calisi, L. Bonanni, M. Onofrj (Chieti, Italy)

    Objective: Olfactory dysfunction due to SARS-CoV-2 infection as a prodromal stage of PD. Background: Olfactory dysfunction due to SARS-CoV-2 disease can depend on the neuroinvasive properties…
  • « Previous Page
  • 1
  • …
  • 119
  • 120
  • 121
  • 122
  • 123
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • Welcome to the MDS Abstracts Site
      • Effect of marijuana on Essential Tremor: A case report
      • Advanced Search
      • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
      • Covid vaccine induced parkinsonism and cognitive dysfunction
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley